Skip to content

AXSOME THERAPEUTICS, INC.: filings

Every AXSOME THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-10fiscal Q2 2026451280001193125-26-342360
10-Q2026-05-04fiscal Q1 202645920001193125-26-204274
10-K2026-02-23fiscal FY 2025471210001193125-26-064267
10-Q2025-11-03fiscal Q3 2025451320001193125-25-262664
10-Q2025-08-04fiscal Q2 2025451280000950170-25-102148
10-Q2025-05-05fiscal Q1 202545910000950170-25-063634
10-K2025-02-18fiscal FY 2024461190000950170-25-022457
10-Q2024-11-12fiscal Q3 2024431200000950170-24-124758
10-Q2024-08-05fiscal Q2 2024431160000950170-24-090828
10-Q2024-05-06fiscal Q1 202442860000950170-24-053697
10-K2024-02-23fiscal FY 2023431060000950170-24-019118
10-Q2023-11-06fiscal Q3 2023431180000950170-23-059470
10-Q2023-08-07fiscal Q2 2023441170000950170-23-039178
10-Q2023-05-09fiscal Q1 202343820000950170-23-018976
10-K2023-02-28fiscal FY 202244990000950170-23-004728
10-Q2022-11-07fiscal Q3 2022441080000950170-22-022710
10-Q2022-08-09fiscal Q2 2022451080000950170-22-016143
10-Q2022-05-02fiscal Q1 202231650000950170-22-006901
10-K2022-03-01fiscal FY 202130780000950170-22-002568
10-Q2021-11-08fiscal Q3 202130790000950170-21-003466
10-Q2021-08-09fiscal Q2 202130750001564590-21-042710
10-Q2021-05-10fiscal Q1 202130600001564590-21-026119
10-K2021-03-01fiscal FY 202030920001564590-21-009924
10-Q2020-11-05fiscal Q3 202027740001558370-20-012949
10-Q2020-08-10fiscal Q2 202027700001558370-20-010231
10-Q2020-05-11fiscal Q1 202027530001558370-20-006302
10-K2020-03-12fiscal FY 201928900001558370-20-002573
10-Q2019-11-07fiscal Q3 201927740001558370-19-010432
10-Q2019-08-08fiscal Q2 201927700001558370-19-007735
10-Q2019-05-09fiscal Q1 201927540001558370-19-004564
10-K2019-03-15fiscal FY 201828890001558370-19-002068
10-Q2018-11-09fiscal Q3 201828680001558370-18-009181
10-Q2018-08-08fiscal Q2 201827640001558370-18-006756
10-Q2018-05-08fiscal Q1 201827540001558370-18-004333
10-K2018-03-07fiscal FY 201725820001558370-18-001639
10-Q2017-11-08fiscal Q3 201727640001558370-17-008545
10-Q2017-08-09fiscal Q2 201726610001558370-17-006445
10-Q2017-05-09fiscal Q1 201726510001558370-17-004014
10-K2017-03-07fiscal FY 201624750001558370-17-001426
10-Q2016-11-14fiscal Q3 201624580001558370-16-010043
10-Q2016-08-09fiscal Q2 201624570001558370-16-007816
10-Q/A2016-08-09fiscal Q1 201624470001558370-16-007810
10-Q2016-05-11fiscal Q1 201624470001558370-16-005875

Inspect the source

Entity
AXSOME THERAPEUTICS, INC. / CIK 0001579428
Captured
2026-09-19T11:19:11.812Z
SEC response SHA-256
bb534249e79901f14ef56a7cde4d7cfc00d4e7cc31cc09f237146d8a497ea5fc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001579428.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))